440 related articles for article (PubMed ID: 15066146)
1. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Kobayashi K; Takeuchi A; Yano A; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
Eur J Neurosci; 2004 Mar; 19(6):1494-504. PubMed ID: 15066146
[TBL] [Abstract][Full Text] [Related]
2. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
3. The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model.
Yasuhara T; Shingo T; Muraoka K; wen Ji Y; Kameda M; Takeuchi A; Yano A; Nishio S; Matsui T; Miyoshi Y; Hamada H; Date I
Brain Res; 2005 Mar; 1038(1):1-10. PubMed ID: 15748867
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease.
Falk T; Yue X; Zhang S; McCourt AD; Yee BJ; Gonzalez RT; Sherman SJ
Neurosci Lett; 2011 May; 496(1):43-7. PubMed ID: 21507340
[TBL] [Abstract][Full Text] [Related]
6. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
[TBL] [Abstract][Full Text] [Related]
7. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
Ebert AD; Beres AJ; Barber AE; Svendsen CN
Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
[TBL] [Abstract][Full Text] [Related]
8. Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors.
Tian YY; Tang CJ; Wang JN; Feng Y; Chen XW; Wang L; Qiao X; Sun SG
Neurosci Lett; 2007 Jun; 421(3):239-44. PubMed ID: 17574749
[TBL] [Abstract][Full Text] [Related]
9. [Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats].
Tian YY; Sun SG; Wang JN; Tang CJ; Feng Y; Wang L; Chen XW; Qiao X
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(29):2054-9. PubMed ID: 17064552
[TBL] [Abstract][Full Text] [Related]
10. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.
Guo S; Yan J; Yang T; Yang X; Bezard E; Zhao B
Biol Psychiatry; 2007 Dec; 62(12):1353-62. PubMed ID: 17624318
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
Falk T; Zhang S; Sherman SJ
Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
[TBL] [Abstract][Full Text] [Related]
14. G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.
Huang HY; Lin SZ; Kuo JS; Chen WF; Wang MJ
Neurobiol Aging; 2007 Aug; 28(8):1258-69. PubMed ID: 16839644
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
16. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
Liu WG; Lu GQ; Li B; Chen SD
Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
20. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
Steiner B; Winter C; Hosman K; Siebert E; Kempermann G; Petrus DS; Kupsch A
Exp Neurol; 2006 Jun; 199(2):291-300. PubMed ID: 16360152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
